418 related articles for article (PubMed ID: 29338693)
1. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China.
Yuan HT; Wang CL; Liu LN; Wang D; Li D; Li ZJ; Liu ZG
Infect Dis Poverty; 2020 Jun; 9(1):79. PubMed ID: 32600403
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.
Abdel-Maksoud M; House B; Wasfy M; Abdel-Rahman B; Pimentel G; Roushdy G; Dueger E
Ann Clin Microbiol Antimicrob; 2012 Aug; 11():24. PubMed ID: 22929054
[TBL] [Abstract][Full Text] [Related]
10. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Ilhan Z; Solmaz H; Ekin IH
J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
13. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
14. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
Sayan M; Kılıc S; Uyanık MH
J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
17. MLVA Genotyping Characteristics of Human
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Tian GZ; Fan WX; Jiang H; Cui BY; Xia XZ
Front Microbiol; 2017; 8():6. PubMed ID: 28149294
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin resistance phenotyping of Brucella melitensis by rpoB gene analysis in clinical isolates.
Sayan M; Yumuk Z; Dündar D; Bilenoglu O; Erdenlig S; Yaşar E; Willke A
J Chemother; 2008 Aug; 20(4):431-5. PubMed ID: 18676221
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
